Nucleoside analogs for antiviral treatment
US8324179B2 · kind B2 · utility
54Cited by
6References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 8, 2008 |
| Grant date | Dec 4, 2012 |
| Priority date | — |
| Expiry date | Jun 8, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention provides unsaturated phosphonates of Formula I or a tautomer or pharmaceutically acceptable salt thereof, as described herein, as well as pharmaceutical compositions comprising the compounds, and therapeutic methods comprising administering the compounds. The compounds have anti-viral properties and are useful for treating viral infections (e.g. HCV) in animals (e.g. humans).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.